Literature DB >> 30462947

[Technical guidelines for seasonal influenza vaccination in China, 2018-2019].

L Z Feng1, Z B Peng1, D Y Wang2, P Yang3, J Yang4, Y Y Zhang5, J Chen6, S Q Jiang7, L L Xu8, M Kang9, T Chen2, Y M Zheng1, J D Zheng1, Y Qin1, M J Zhao10, Y Y Tan11, Z J Li1, Z J Feng12.   

Abstract

Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and its complications. Currently, China has licensed trivalent (IIV3) and quadrivalent inactivated influenza vaccine (IIV4), including split-virus influenza vaccine and subunit vaccine. In most parts of China, influenza vaccine is a category Ⅱ vaccine, which means influenza vaccination is voluntary, and recipients need to pay for it. To strengthen the technical guidance for prevention and control of influenza and the operational research on influenza vaccination in China, the National Immunization Advisory Committee (NIAC), Influenza Vaccine Technical Working Group (TWG), updated the 2014 technical guidelines and compiled the "Technical guidelines for seasonal influenza vaccination in China (2018-2019)" , based on most recent existing scientific evidences. The main updates include: epidemiology and disease burden of influenza, types of influenza vaccines, northern hemisphere influenza vaccination composition for the 2018-2019 season, and, IIV3 and IIV4 vaccines'major immune responses, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. The recommendations include: Points of Vaccination clinics (PoVs) should provide influenza vaccination to all persons aged 6 months and above who are willing to be vaccinated and do not have contraindications. No preferential recommendation is made for any influenza vaccine product for persons who can accept ≥1 licensed, recommended, and appropriate products. To decrease the risk of severe infections and complications due to influenza virus infection among high risk groups, the recommendations prioritize seasonal influenza vaccination for children aged 6-60 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, the family members and caregivers of infants <6 months of age, and pregnant women or women who plan to pregnant during the influenza season. Children aged 6 months to 8 years old require 2 doses of influenza vaccine administered a minimum of 4 weeks apart during their first season of vaccination for optimal protection. If they were vaccinated in previous influenza season, 1 dose is recommended. People ≥ 9 years old require 1 dose of influenza vaccine. It is recommended that people receive their influenza vaccination by the end of October. Influenza vaccination should be offered as soon as the vaccination is available. Influenza vaccination should continue to be available for those unable to be vaccinated before the end of October during the whole season. Influenza vaccine is also recommended for use in pregnant women during any trimester. These guidelines are intended for CDC members who are working on influenza control and prevention, PoVs members, healthcare workers from the departments of pediatrics, internal medicine, and infectious diseases, and members of maternity and child care institutions at all levels.

Entities:  

Keywords:  Disease burden; Influenza; Technical guideline; Vaccination; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 30462947     DOI: 10.3760/cma.j.issn.0254-6450.2018.11.001

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  7 in total

1.  Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.

Authors:  Suizan Zhou; Carolyn M Greene; Ying Song; Ran Zhang; Lance E Rodewald; Luzhao Feng; Alexander J Millman
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

2.  Influenza-associated Hospitalization in Children Younger Than 5 Years of Age in Suzhou, China, 2011-2016.

Authors:  Jia Yu; Xiyan Zhang; Wei Shan; Junmei Gao; Jun Hua; Jianmei Tian; Yunfang Ding; Jun Zhang; Liling Chen; Ying Song; Suizan Zhou; A Danielle Iuliano; Carolyn M Greene; Tao Zhang; Genming Zhao
Journal:  Pediatr Infect Dis J       Date:  2019-05       Impact factor: 2.129

Review 3.  The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy.

Authors:  Kathleen F Morales; Lisa Menning; Philipp Lambach
Journal:  Vaccine       Date:  2020-06-02       Impact factor: 3.641

4.  Determinants of Willingness of Patients with Type 2 Diabetes Mellitus to Receive the Seasonal Influenza Vaccine in Southeast China.

Authors:  Wei Feng; Jun Cui; Hui Li
Journal:  Int J Environ Res Public Health       Date:  2019-06-21       Impact factor: 3.390

Review 5.  Chinese expert consensus on immunoprophylaxis of common respiratory pathogens in children (2021 edition).

Authors:  Zifeng Yang; Tiejian Feng; Wenda Guan; Jianfeng He; Rongmeng Jiang; Gang Liu; Gen Lu; Quan Lu; Adong Shen; Lihong Sun; Xiaodong Sun; Yonghong Yang; Mei Zeng; Jiushun Zhou; Kunling Shen; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

6.  Knowledge, Attitudes, and Behaviors (KAB) of Influenza Vaccination in China: A Cross-Sectional Study in 2017/2018.

Authors:  Xiang Ren; Elizabeth Geoffroy; Keqing Tian; Liping Wang; Luzhao Feng; Jun Feng; Ying Qin; Peng Wu; Shaosen Zhang; Mengjie Geng; Lingjia Zeng; Jianxing Yu; Benjamin J Cowling; Zhongjie Li
Journal:  Vaccines (Basel)       Date:  2019-12-26

7.  Influenza A and B outbreaks differed in their associations with climate conditions in Shenzhen, China.

Authors:  Pan Ma; Xiaoxin Tang; Li Zhang; Xinzi Wang; Weimin Wang; Xiaoling Zhang; Shigong Wang; Ning Zhou
Journal:  Int J Biometeorol       Date:  2021-10-25       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.